Synergy CHC (SNYR) Company Sales Revenue

Synergy CHC - graphic logo of issuer SNYR

Declining e-commerce loyalty and rising promotion costs are squeezing the margins of Synergy CHC Corp (SNYR). Demand for wellness products is moderately cyclical and dependent on household budgets. The company's current sales volume visualizes these fluctuations, where 0.03 shows the current value of the metric. Meanwhile, management is focusing on distribution and asset optimization to capitalize on consumer brands.

Synergy CHC Corp. (SNYR) Company Sales: for the period 10/24/2024 - 10/03/2026

Comprehensive metric breakdowns and analytics for Synergy CHC Corp. (SNYR)

- market price and analyst price targets:
Comprehensive company analysis:Synergy CHC - SNYR
Product sample of Synergy CHC

Synergy CHC Corp (SNYR) capitalizes on beauty product consumer loyalty to create a sustainable cash flow. Analyzing the company's retail revenue trend, an investor sees the current value of 0.03. This metric captures daily operational inflows, reflecting the actual volume of commercial sales and the demand balance. Real-time monitoring of such revenues allows for the assessment of the asset's fundamental value, eliminating the risk of a capital drawdown.

Key competitors

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Revenue and Sales Volume|SXTC (China SXT Pharmaceuticals, Inc.) - Company Total Sales|Company Revenue eupraxiapharma.com (EPRX)|Company Total Sales BHST|Company Revenue eXoZymes EXOZ|Company Sales Revenue ORMP|ENTX - Company Revenue|HYFT: Company Revenue|ABVC BioPharma, Inc (ABVC) - Company Revenue|Cumberland Pharma - Company Sales Revenue|QNTM (Quantum BioPharma Corp) - Revenue and Sales Volume|FibroGen, Inc. - Company Annual Revenue|Revenue and Sales Volume TELO|Company Gross Revenue Rani Therapeutics Holdings, Inc.|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP